HIPEC For Peritoneal Surface Malignancies Including Carcinomatosis or Sarcomatosis - Data Registry

December 06, 2013
HIPEC
Appendiceal Cancer, Colorectal Cancer, Gastric Adenocarcinoma, Mesothelioma, Ovarian Cancer, Pseudomyxoma peritonei, Sarcoma, Surgical
George I Salti, MD

Naperville, Plainfield

In this study we will collect data about your disease, your treatment, and how you respond to treatment to include in both our local and national databases.  The information in these databases can then be used to answer questions about cryoreductive surgery and HIPEC such as how well it is tolerated in different populations or how effective it is in treating specific types of disease.  We want these databases to contain sufficient information to help answer those questions.  This study only involved the collection of data; your treatment will not be experimental.

Sponsor: Edward Hospital

http://clinicaltrials.gov/ct2/show/NCT02082886?term=NCT02082886&rank=1

The sole inclusion criteria for this study will be those consenting patients who are to undergo cytoreductive surgery followed by HIPEC at Edward Hospital, Naperville.

Lifetime

Accepting Participants
Registry
Kathy Seymour, BSN
630-646-6050
630-646-6110
630-646-6075